Prospective, single-centre, randomised controlled trial to evaluate the efficacy and safety of ischaemia-free liver transplantation (IFLT) in the treatment of end-stage liver disease.
Huang C, Huang S, Tang Y, Zhao Q, Wang D, Ju W, Yang L, Zhang J, Wu L, Chen M, Zhang Z, Zhu Z, Wang L, Zhu C, Zhang Y, Sun C, Xiong W, Shen Y, Chen X, Ma Y, Hu A, Zhu X, Rong J, Cai C, Guo Z, He X.
Huang C, et al. Among authors: ma y.
BMJ Open. 2020 May 5;10(5):e035374. doi: 10.1136/bmjopen-2019-035374.
BMJ Open. 2020.
PMID: 32376754
Free PMC article.